JP2023520323A5 - - Google Patents

Info

Publication number
JP2023520323A5
JP2023520323A5 JP2022557150A JP2022557150A JP2023520323A5 JP 2023520323 A5 JP2023520323 A5 JP 2023520323A5 JP 2022557150 A JP2022557150 A JP 2022557150A JP 2022557150 A JP2022557150 A JP 2022557150A JP 2023520323 A5 JP2023520323 A5 JP 2023520323A5
Authority
JP
Japan
Prior art keywords
use according
compound
virus
respiratory
pharmaceutically acceptable
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2022557150A
Other languages
English (en)
Japanese (ja)
Other versions
JP7671305B2 (ja
JP2023520323A (ja
Filing date
Publication date
Priority claimed from GBGB2004209.9A external-priority patent/GB202004209D0/en
Priority claimed from GBGB2009574.1A external-priority patent/GB202009574D0/en
Priority claimed from US17/113,416 external-priority patent/US11123329B1/en
Application filed filed Critical
Publication of JP2023520323A publication Critical patent/JP2023520323A/ja
Publication of JP2023520323A5 publication Critical patent/JP2023520323A5/ja
Application granted granted Critical
Publication of JP7671305B2 publication Critical patent/JP7671305B2/ja
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2022557150A 2020-03-23 2021-03-22 2型アンギオテンシンii受容体アゴニストの新規使用 Active JP7671305B2 (ja)

Applications Claiming Priority (7)

Application Number Priority Date Filing Date Title
GBGB2004209.9A GB202004209D0 (en) 2020-03-23 2020-03-23 New use
GB2004209.9 2020-03-23
GB2009574.1 2020-06-23
GBGB2009574.1A GB202009574D0 (en) 2020-06-23 2020-06-23 New use
US17/113,416 US11123329B1 (en) 2020-03-23 2020-12-07 Use of angiotensin II type 2 receptor agonist
US17/113,416 2020-12-07
PCT/GB2021/050699 WO2021191592A1 (en) 2020-03-23 2021-03-22 New use of angiotensin ii type 2 receptor agonist

Publications (3)

Publication Number Publication Date
JP2023520323A JP2023520323A (ja) 2023-05-17
JP2023520323A5 true JP2023520323A5 (cg-RX-API-DMAC7.html) 2024-04-03
JP7671305B2 JP7671305B2 (ja) 2025-05-01

Family

ID=77747178

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2022557150A Active JP7671305B2 (ja) 2020-03-23 2021-03-22 2型アンギオテンシンii受容体アゴニストの新規使用

Country Status (12)

Country Link
US (2) US11123329B1 (cg-RX-API-DMAC7.html)
EP (1) EP4125881B1 (cg-RX-API-DMAC7.html)
JP (1) JP7671305B2 (cg-RX-API-DMAC7.html)
CN (1) CN115605201A (cg-RX-API-DMAC7.html)
CA (1) CA3176108A1 (cg-RX-API-DMAC7.html)
ES (1) ES2992423T3 (cg-RX-API-DMAC7.html)
HR (1) HRP20241435T1 (cg-RX-API-DMAC7.html)
HU (1) HUE068662T2 (cg-RX-API-DMAC7.html)
PL (1) PL4125881T3 (cg-RX-API-DMAC7.html)
RS (1) RS66072B1 (cg-RX-API-DMAC7.html)
SM (1) SMT202400427T1 (cg-RX-API-DMAC7.html)
WO (1) WO2021191592A1 (cg-RX-API-DMAC7.html)

Families Citing this family (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB202004094D0 (en) * 2020-03-20 2020-05-06 Vicore Pharma Ab New compounds and uses
US20220233480A1 (en) * 2020-03-23 2022-07-28 Vicore Pharma Ab Use of angiotensin ii type 2 receptor agonist
JP7798791B2 (ja) * 2020-04-22 2026-01-14 エアウェイ・セラピューティクス・インコーポレイテッド ウイルス感染症の治療のための肺サーファクタントタンパク質dの使用
CN117209555B (zh) * 2021-09-30 2024-12-03 中国科学院上海药物研究所 一类氰基化合物、其制备方法及用途
CN115583984A (zh) * 2022-01-11 2023-01-10 嘉兴安谛康生物科技有限公司 氮杂螺类化合物及其制备方法、药物组合物和用途
CN114948950A (zh) * 2022-01-19 2022-08-30 广州谷森制药有限公司 一种药物组合物及其抗病毒用途
TW202432112A (zh) * 2023-01-16 2024-08-16 大陸商海南先聲藥業有限公司 抗病毒藥物組合物及其製備方法

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE60222409T2 (de) 2001-05-31 2008-09-25 Vicore Pharma Ab Trizyklische verbindungen, nützlich als angiotensin ii agonisten
EP1723962A1 (en) 2005-05-19 2006-11-22 IMBA-Institut für Molekulare Biotechnologie GmbH Use of inhibitors of the renin-angiotensin system for the treatment of lung injuries
HK1244232A1 (zh) 2015-03-02 2018-08-03 维科尔药物公司 用於治疗肺纤维化的血管紧张素ii受体激动剂
GB201818164D0 (en) 2018-11-07 2018-12-19 Vicore Pharma Ab New composition

Similar Documents

Publication Publication Date Title
HRP20241435T1 (hr) Nova upotreba agonista angiotenzinskog ii receptora tipa 2
CN111297838A (zh) 一种抗病毒药物的吸入喷雾剂
RU2411039C2 (ru) Иммунокорригирующее средство для лечения заболеваний вирусной этиологии
Hon et al. Respiratory syncytial virus is the most common causative agent of viral bronchiolitis in young children: an updated review
CN113304166A (zh) 核苷类化合物在治疗冠状病毒感染性疾病中的用途
JP2024504225A5 (cg-RX-API-DMAC7.html)
JP2010270130A5 (cg-RX-API-DMAC7.html)
JP2025508656A5 (cg-RX-API-DMAC7.html)
WO2021203702A1 (zh) 焦谷氨酸在制备预防和治疗新冠肺炎新型冠状病毒的药物中的应用
JP2024545086A (ja) 抗ウイルス治療剤及びその使用
CN112386595A (zh) 一种治疗呼吸系统病毒性感染的药物组合物
EP2285393B1 (en) Compositions for the treatment of disorders of the upper respiratory tract and influenza syndromes
JP2026077677A (ja) コロナウイルス感染症の処置のための方法
WO2021195521A1 (en) Methods of treating coronavirus infections
KR20190009294A (ko) 비강 울혈을 치료/예방하기 위한 카르복실산
US20030045577A1 (en) Method for preventing infectious respiratory diseases
CN113855685A (zh) 糖皮质激素在制备治疗和/或预防呼吸道病毒感染的药物中的用途
WO2016036273A1 (ru) Лекарственное средство для профилактики и лечения заболеваний дыхательных путей
WO2022199049A1 (zh) 乌司他丁在制备治疗新型冠状病毒肺炎药物中的用途
JP2023520929A5 (cg-RX-API-DMAC7.html)
US11497747B2 (en) Compositions and methods for treating lung injuries associated with SARS-CoV-2 infections
CN118845782A (zh) Zinc62678696在防治肺炎中的应用
JP2024543259A5 (cg-RX-API-DMAC7.html)
IT201800002457A1 (it) Composizione per la prevenzione e il trattamento delle affezioni delle vie respiratorie
JPH09227373A (ja) 抗インフルエンザウイルス剤